StockDuty ← Dashboard Oct 02, 2026 02:00 AM ET
SignalEU/UK

AstraZeneca (AZN) Puts $2 Billion Into Summit Therapeutics (SMMT) for a Cancer Tie-Up

AstraZeneca's $2 billion investment in Summit Therapeutics signals major cancer deal catalyst.

AstraZeneca's $2 billion investment in Summit Therapeutics signals major cancer deal catalyst.
AstraZeneca's $2 billion investment in Summit Therapeutics signals major cancer deal catalyst. — impact context not separately stored; see What changed.
Sources